Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving oxidoreductase
Reexamination Certificate
2007-03-27
2007-03-27
Wax, Robert A. (Department: 1656)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving oxidoreductase
C435S007210
Reexamination Certificate
active
10824027
ABSTRACT:
Proteins modified by pharmacological preconditioning are provided. Compositions, methods and events for modulating these proteins and priming cells for preconditioning and inducing preconditioning in a cell, tissue or organ as well as methods for identifying new compositions and methods for such priming and induction are also provided. In addition, methods for diagnosing and monitoring preconditioning or ischemic, hypoxic, ischemic/reperfusion and hypoxic/reperfusion conditions or the ability of a cell, tissue or organ to survive injury by measuring modulation of one or more of these preconditioning proteins are provided.
REFERENCES:
patent: 4880783 (1989-11-01), Mentzer, Jr. et al.
patent: 6165977 (2000-12-01), Mochly-Rosen
patent: 6790634 (2004-09-01), Van Eyk et al.
patent: 2003/0022220 (2003-01-01), Van Eyk et al.
patent: 2 356 499 (2003-02-01), None
patent: WO 03/004693 (2003-01-01), None
Wang, Y. et al. J. Mol. Cell. Cardiol. 33:2037-2046 (2001).
Currie et al. Brain Research 863: 169-181 (2000) “Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27”.
Kobara et al. J Mol Cell Cardiol 28: 417-428 (1996) “Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts”.
Nakagawa et al., “ATP-dependent potassium channel mediates neuroprotection by chemical preconditioning with 3-nitropropionic acid gerbil hippocampus”, Neuroscience Letters 320: 33-36 (2002).
Tanaka et al., “Synergistic induction of HSP40 and HSC70 in the mouse hippocampal neurons after cerebral ischemia and ischemic tolerance in gerbil hippocampus”, Journal of Neuroscience Research 67: 37-47 (2002).
Ala-Rami, A., et al. “Ischaemic preconditioning and a mitochondrial KATP channel opener both produce cardioprotection accompanied by F1F0-ATPase inhibition in early ischaemia.” Basic Res. Cardiol. 98: 250-258 (2003).
Bolli, R. “The late phase of preconditioning.” Circ. Res. 87: 972-983 (2000).
Dana, A., et al. “Adenosine A1 receptor induced delayed preconditioning in rabbits. Induction of p38 mitogen-activated protein kinase activation and Hsp27 phosporylation via a tyrosine kinase- and protein kinase C-dependent mechanism.” Circ. Res. 86: 989-997 (2000).
Hanley, P.J., et al. “Halothane, isoflurane and sevoflurane inhibit NADH: ubiquinone oxidoreductase (complex I) of cardiac mitochondria,” J. Physiol. 554.3: 687-693 (2002).
Kloner, R.A., et al. “Consequences of brief ischemia: stunning, preconditioning, and their clinical implications.” Circulation 104: 2981-2989 (2001).
Schafer, G., et al. “Diazoxide, an inhibitor of succinate oxidation.” Biochem. Phama. 18: 2678-2681 (1969).
Schafer, G., et al. “Inhibition of mitochondrial metabolism by the diabetogenic thiadiazine diazoxide-I. Action on succinate dehydrogenase and TCA-cycle oxidations.” Biochem. Pharma. 20: 1271-1280 (1971).
Thornton, J., et al. “Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning.” Am. J. Physiol. 259: H1822-H1825 (1990).
Hanley et al., “KATPchannel-independent targets of diazoxide and 5-hydroxydecanoate in the heart”, Journal of Physiology 2002 542.3:735-741.
Arrell et al., “Proteomic Analysis of Pharmacological Preconditioning Novel Protein Targets Converge to Mitochondrial Metabolism Pathways”, Cir Res. 2006 99:706-714 with online Supplemement.
Arrell et al., “Proteomic Analysis of Pharmacologically Preconditioned Cardiomyocytes Reveals Novel Phosphorylation of Myosin Light Chain 1”, Cir Res. 2001 89:480-487.
Liu et al., “Synergistic Modulation of ATP-Sensitive K+Currents by Protein Kinase C and Adenosine”, Circulation Research 1996 78:443-454.
Sato et al., “Adenosine Primes the Opening of Mitochondrial ATP-Sensitive Potassium Channels: A Key Step in Ischemic Preconditioning?” Circulation 2000 102:800-805.
Steinberg, Robert A., “Cyclic AMP-dependent Phosphorylation of the Precursor to β Subunit of Mitochondrial F1-ATPase:A Physiological Mistake?”, The Journal of Cell Biology 1984 98:2174-2178.
Ylitalo et al., “Reversible ischemic inhibition of F1F0-ATPase in rat and human myocardium”, Biochimica et Biophysica Acta 1504 2001 329-339.
Arrell David Kent
Elliott Steven T.
Van Eyk Jennifer E.
Desai Anand
Licata & Tyrrell P.C.
Queen's University at Kingston
Wax Robert A.
LandOfFree
Methods and compositions for modulating proteins modified in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for modulating proteins modified in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for modulating proteins modified in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3763009